Item 2.02. Results of Operations and Financial Condition
On March 1, 2021, Clover Health Investments, Corp.. (the "Company") issued a
press release and letter to its shareholders announcing its financial results
for the fourth quarter and fiscal year ended December 31, 2020. The full text of
the press release and shareholder letter issued in connection with the
announcement are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, to
this Current Report on Form 8-K.
The information set forth in this Item 2.02 (including Exhibits 99.1 and 99.2)
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a
filing.
Item 7.01 Regulation FD Disclosure.
Investors and others should note that the Company routinely announces material
information to investors and the marketplace using filings with the U.S.
Securities and Exchange Commission (the "SEC"), press releases, public
conference calls, presentations, webcasts and the Clover Health Investor
Relations website. The Company also intends to use certain social media channels
as a means of disclosing information about the company and its products to its
customers, investors and the public (e.g., @Clover_Health and #CloverHealth on
Twitter). The information posted on social media channels is not incorporated by
reference in this report or in any other report or document the Company files
with the SEC. While not all of the information that the Company posts to the
Clover Health Investor Relations website or to social media accounts is of a
material nature, some information could be deemed to be material. Accordingly,
the Company encourages investors, the media, and others interested in the
Company to review the information that it shares at the "Investors" link located
at the bottom of its webpage at
https://investors.cloverhealth.com/investor-relations and to sign up for and
regularly follow the Company's social media accounts. Users may automatically
receive email alerts and other information about the Company when enrolling an
email address by visiting "Email Alerts" in the "Investor Resources" section of
the Company's website at https://investors.cloverhealth.com/investor-relations.
Item 9.01 Financial Statements and Exhibits.
(d) List of Exhibits.
Exhibit No. Description
99.1 Press release dated March 1, 2021.
99.2 Letter to Shareholders, dated March 1, 2021
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses